The next SARS-CoV-2 variant up is JN.1, a BA.2.86 add on, which differs considerably cf HV.1 (current US lead), EF.5.1, XBB.1.5 (booster target). It's likely to further challenge our immune response (spike mutation map below) and main results from Yunlong Cao's lab